MarketPulse

loss of exclusivity

2 articles
BenzingaBenzinga··Nabaparna Bhattacharya

Amneal Pharmaceuticals Surges on $1.1B Kashiv Acquisition to Dominate Biosimilars

Amneal Pharmaceuticals surged 3.76% after agreeing to acquire Kashiv BioSciences for $1.1 billion, positioning itself in the $300 billion biosimilars market.
AMRXXPHASCEacquisitionstrategic partnership
BenzingaBenzinga··Vandana Singh

Sanofi Shares Slide as Hudson Steps Down; Garijo to Lead Post-AGM

Sanofi CEO Paul Hudson steps down February 17; Belén Garijo takes over post-AGM. Stock fell 4.5% on leadership transition announcement amid vaccine sales decline concerns.
SNYREGNstock declineCEO transition